Runner-agnostic execution
Run your existing suites where they live — GitHub Actions today, runner-agnostic by design. Sentula orchestrates; you keep your pipeline.
Sentula runs your medical device's own test suites and turns every run into traceable, IEC 62304–aligned FDA evidence — ready for 21 CFR Part 11 sign-off in the QMS you already run.
Purpose-built for FDA-regulated medical software — from Class II devices to AI/ML-enabled Software as a Medical Device. Fluent in the standards your auditors already expect:
Today your team rebuilds compliance evidence by hand after every release — the manual binder that can consume a large share of a device's cost to market. Then the next commit resets it.
of the cost to bring a medical device to market is regulatory & compliance work. (Stanford, 2010)
FDA-authorized AI/ML devices, 2015 to today — the cadence of change is exploding.
re-proves the same requirements, by hand, from zero. The change rate is only climbing.
Sentula makes compliance evidence a by-product of running your tests — not a project you start after the release.
Execute your existing suites where they already run — GitHub Actions today, runner-agnostic by design. No rip-and-replace.
Collect the proof each run produces — logs, artifacts, and visual proof of the software behaving as specified — every artifact hashed and attributed the moment it lands.
Link every result back to the requirement it satisfies — requirement → risk → test → evidence, kept live.
Route to QA for 21 CFR Part 11 sign-off with a tamper-evident audit trail — then deliver a signed, track-changes-ready record into the QMS you already run.
Traceability backbones store the evidence you upload and run tests through external integrations. Sentula adds the missing half: a built-in executor that generates the evidence, then assembles it into the sign-off-ready, track-changes document your QMS expects — feeding whatever backbone you already run.
Under your QMS, over your test pipeline.
Run your existing suites where they live — GitHub Actions today, runner-agnostic by design. Sentula orchestrates; you keep your pipeline.
Test evidence is captured on every run — logs, artifacts, and visual proof of the software doing exactly what the spec requires — hashed, attributed, and linked as it lands.
Every result is linked requirement → risk → test → evidence — the IEC 62304 / ISO 14971 trace kept live instead of going stale between audits. An agentic trace-keeper proposes missing links and flags coverage holes; every proposal lands as an attributed change a human approves.
Your QA team holds approval and signs each record with a tamper-evident audit trail. Authority stays with people, not the machine.
When code or a model changes, the evidence regenerates rather than resetting your validation to zero.
Delivered as a signed evidence bundle you upload — or an API push where that's cleaner. Whatever QMS you run, or none: no lock-in to one backbone, no rip-and-replace.
Three regulatory shifts now favor risk-based, executable proof over hand-assembled binders — exactly what Sentula produces.
The Quality Management System Regulation incorporates ISO 13485:2016 by reference — aligning U.S. device quality with a globally harmonized standard.
Computer Software Assurance for Production and Quality Management System Software — the Feb 3, 2026 revision supersedes the 2025 final. Risk-based, test-evidence-driven assurance is unchanged: less paperwork, more proof from the tests themselves.
Predetermined Change Control Plans let AI-enabled devices evolve under a pre-authorized envelope — change becomes continuous, and so must the evidence.
Sentula is agentic where that saves you weeks — proposing trace links, drafting the record, capturing visual proof of the running software. And it is deterministic where an auditor needs it: pass/fail comes only from executing your tests, every artifact is hashed into a tamper-evident chain, and the same inputs always regenerate the same record. Every AI contribution arrives as an attributed proposal a human approves — and the permission model itself makes it impossible for an agent to sign. Not a policy. An invariant.
A tool only enters a regulated stack with a head-nod from engineering, product, quality, and the executive team. Sentula is designed so each seat keeps what it owns — and sheds the manual work.
Your CI and runners stay exactly as they are. Sentula instruments the suites you already run and turns each run into attributed, traceable evidence — the evidence-to-document grunt work stops landing on engineering.
When code or a model changes, the evidence regenerates instead of resetting validation to zero — compliance stops being the step that adds months to every release.
Deterministic and reproducible: the same inputs yield the same proof, your team holds every Part 11 signature, and you can replay any line of the record in front of an auditor.
Sentula hands your QMS a controlled, sign-off-ready record — a signed evidence bundle you upload, or an API push where that's cleaner. Nothing about your Part 11 process changes.
An evidence layer over the pipeline you already run — no re-architecting the SDLC, no rip-and-replace. Pass/fail comes from your tests, not a model's judgment.
Regulatory and compliance work is the biggest share of a device's cost to market — and it recurs on every release. Sentula turns that recurring manual cost into a by-product of the tests you already run.
Join the early-access cohort. We're onboarding a small set of FDA-regulated medical-device and SaMD teams ahead of general availability.